|
|
Volumn 358, Issue 9292, 2001, Pages 1546-1548
|
|
Further comments on fibrosing colonopathy study [1] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PANCREAS ENZYME;
POLYACRYLIC ACID;
PANCRELIPASE;
PANCREAS EXTRACT;
CHILD;
CLINICAL FEATURE;
COLON DISEASE;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
DISEASE COURSE;
DRUG CAPSULE;
DRUG COATING;
DRUG FORMULATION;
DRUG INFUSION;
ENTEROPATHY;
ENZYME SYNTHESIS;
HEALTH STATUS;
HISTOPATHOLOGY;
HUMAN;
INFUSION;
LETTER;
LONGITUDINAL STUDY;
MAJOR CLINICAL STUDY;
MEDICAL ASSESSMENT;
MEDICAL RECORD;
PATHOLOGIST;
PRIORITY JOURNAL;
RISK FACTOR;
SAMPLING;
TOXICITY;
VALIDATION PROCESS;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
FACTUAL DATABASE;
NOTE;
UNITED KINGDOM;
HEALTH PERSONNEL ATTITUDE;
PATHOLOGY;
CHILD;
COLONIC DISEASES;
CYSTIC FIBROSIS;
DATABASES, FACTUAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GREAT BRITAIN;
HUMANS;
PANCRELIPASE;
ATTITUDE OF HEALTH PERSONNEL;
MEDICAL RECORDS;
PANCREATIC EXTRACTS;
|
|
EID: 0035802681
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(01)06591-6 Document Type: Letter |
|
Times cited : (11)
|
|
References (4)
|
